Literature DB >> 7020879

In vivo activity of purified mouse brain renin.

G Speck, K Poulsen, T Unger, R Rettig, C Bayer, B Schölkens, D Ganten.   

Abstract

Mouse brain renin and kidney renin were purified by a 3-step procedure: acetone powder extraction. Sephadex G-100 chromatography, and blue agarose affinity chromatography. The latter efficiently separated from cathepsin D-like acid protease activity. Mouse brain renin had an optimum of enzyme activity of pH 7.0. This differed from mouse kidney renin, which had an optimum at pH 8.5. In vitro, brain renin formed angiotensin I from rat plasma angiotensinogen and had no angiotensinase activity. Mouse brain renin was inhibited by monospecific antibodies raised against pure mouse submandibular gland renin. In vivo activity of the enzyme was tested by injection of brain renin into the lateral brain ventricle of rats. This resulted in the formation of angiotensin I from endogenous brain angiotensinogen, in the stimulation of water uptake, and in a long-lasting increase of arterial blood pressure. The latter could be blocked by the competitive angiotensin II receptor antagonist, saralasin. The results showed that brain renin is active under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020879     DOI: 10.1016/0006-8993(81)90300-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy.

Authors:  Justin L Grobe; Di Xu; Curt D Sigmund
Journal:  Physiology (Bethesda)       Date:  2008-08

Review 2.  Development of fetal brain renin-angiotensin system and hypertension programmed in fetal origins.

Authors:  Caiping Mao; Lijun Shi; Feichao Xu; Lubo Zhang; Zhice Xu
Journal:  Prog Neurobiol       Date:  2009-01-24       Impact factor: 11.685

3.  (Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells.

Authors:  Hua Peng; Wencheng Li; Dale M Seth; Anand R Nair; Joseph Francis; Yumei Feng
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.